FLUIDX MEDICAL TECHNOLOGY, INC. — Form D
FLUIDX MEDICAL TECHNOLOGY, INC. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-03. The offering totals $1.3M, of which $346K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-04-03
- Form: D
- Accession: 0001949875-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $346K
- Remaining: $929K
- Investors: 1
- Date of first sale: 2024-03-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509465
Issuer
- Name: FLUIDX MEDICAL TECHNOLOGY, INC.
- CIK: 0001949875
- Entity type: Corporation
- Jurisdiction: UTAH
- Address: 2500 S. STATE STREET, SUITE D246, SALT LAKE CITY, UT, 84115
- Phone: (435) 893-1555
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| MICHAEL PATRICK DAKE | Director | SALT LAKE CITY, UT |
| SHAWN PATRICK FOJTIK | Director | SALT LAKE CITY, UT |
| GREG PATRICK FREDDE | Director | SALT LAKE CITY, UT |
| JAMES PATRICK McGUCKIN | Director | SALT LAKE CITY, UT |
| KAREN GINSTER | Director | SALT LAKE CITY, UT |
| KAREN GINSTER | Executive Officer | SALT LAKE CITY, UT |
| Lawrence Patrick Kronick | Director | Salt Lake City, UT |
| Gregory A Fredde | Director | Salt Lake City, UT |
Other filings by this issuer (4)
More